Peer Review reports
From: CD1C is associated with breast cancer prognosis and immune infiltrates
| Original Submission | ||
|---|---|---|
| 2 Jun 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 15 Nov 2022 | Reviewed | Reviewer Report |
| 4 Dec 2022 | Reviewed | Reviewer Report |
| 30 Dec 2022 | Author responded | Author comments - Wenjun Jia |
| Resubmission - Version 4 | ||
| 30 Dec 2022 | Submitted | Manuscript version 4 |
| 6 Jan 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 18 Jan 2023 | Editorially accepted | |
| 8 Feb 2023 | Article published | 10.1186/s12885-023-10558-2 |
You can find further information about peer review here.